PanGen Biotech (Korea) Buy Hold or Sell Recommendation
| 222110 Stock | KRW 6,000 290.00 4.61% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding PanGen Biotech is 'Cautious Hold'. Macroaxis provides PanGen Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 222110 positions.
Check out PanGen Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as PanGen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards PanGen Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
PanGen |
Execute PanGen Biotech Buy or Sell Advice
The PanGen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on PanGen Biotech. Macroaxis does not own or have any residual interests in PanGen Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute PanGen Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
PanGen Biotech Trading Alerts and Improvement Suggestions
| PanGen Biotech is way too risky over 90 days horizon | |
| PanGen Biotech appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 7.94 B. Net Loss for the year was (3.31 B) with profit before overhead, payroll, taxes, and interest of 1.35 B. | |
| PanGen Biotech has accumulated about 8.9 B in cash with (3.32 B) of positive cash flow from operations. | |
| Roughly 33.0% of the company shares are owned by insiders or employees |
PanGen Biotech Returns Distribution Density
The distribution of PanGen Biotech's historical returns is an attempt to chart the uncertainty of PanGen Biotech's future price movements. The chart of the probability distribution of PanGen Biotech daily returns describes the distribution of returns around its average expected value. We use PanGen Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of PanGen Biotech returns is essential to provide solid investment advice for PanGen Biotech.
| Mean Return | 0.69 | Value At Risk | -6.1 | Potential Upside | 9.20 | Standard Deviation | 5.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of PanGen Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
PanGen Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to PanGen Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that PanGen Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a PanGen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.64 | |
β | Beta against Dow Jones | 0.33 | |
σ | Overall volatility | 5.87 | |
Ir | Information ratio | 0.10 |
PanGen Biotech Volatility Alert
PanGen Biotech shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure PanGen Biotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact PanGen Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.PanGen Biotech Fundamentals Vs Peers
Comparing PanGen Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PanGen Biotech's direct or indirect competition across all of the common fundamentals between PanGen Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as PanGen Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of PanGen Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing PanGen Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PanGen Biotech to competition |
| Fundamentals | PanGen Biotech | Peer Average |
| Return On Equity | -24.89 | -0.31 |
| Return On Asset | -0.079 | -0.14 |
| Profit Margin | (0.92) % | (1.27) % |
| Operating Margin | (0.82) % | (5.51) % |
| Current Valuation | 90.89 B | 16.62 B |
| Shares Outstanding | 9.64 M | 571.82 M |
| Shares Owned By Insiders | 33.33 % | 10.09 % |
| Shares Owned By Institutions | 2.47 % | 39.21 % |
| Price To Sales | 13.35 X | 11.42 X |
| Revenue | 7.94 B | 9.43 B |
| Gross Profit | 1.35 B | 27.38 B |
| EBITDA | (3.07 B) | 3.9 B |
| Net Income | (3.31 B) | 570.98 M |
| Cash And Equivalents | 8.9 B | 2.7 B |
| Total Debt | 5.49 M | 5.32 B |
| Debt To Equity | 1.52 % | 48.70 % |
| Current Ratio | 1.12 X | 2.16 X |
| Cash Flow From Operations | (3.32 B) | 971.22 M |
| Number Of Employees | 7 | 18.84 K |
| Beta | 0.74 | -0.15 |
| Market Capitalization | 59.88 B | 19.03 B |
| Total Asset | 43.28 B | 29.47 B |
| Net Asset | 43.28 B |
PanGen Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as PanGen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 5652.73 | |||
| Daily Balance Of Power | (0.56) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 6140.0 | |||
| Day Typical Price | 6093.33 | |||
| Market Facilitation Index | 0.0075 | |||
| Price Action Indicator | (285.00) | |||
| Period Momentum Indicator | (290.00) | |||
| Relative Strength Index | 63.22 |
About PanGen Biotech Buy or Sell Advice
When is the right time to buy or sell PanGen Biotech? Buying financial instruments such as PanGen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having PanGen Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in PanGen Stock
PanGen Biotech financial ratios help investors to determine whether PanGen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PanGen with respect to the benefits of owning PanGen Biotech security.